Clinical trial Recruiting at 5 sites Interventional Ages 18 to 45 Women only

Comparing glycemic targets in overweight and obese women with gestational diabetes

Official title: Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Mellitus: A Multicenter Randomized Trial

Run by Indiana University · NCT05124808 · Data updated 2026-11-12

This study tests whether setting stricter blood sugar goals during pregnancy helps overweight and obese women with gestational diabetes have better outcomes for themselves and their babies.

More Gestational Diabetes trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment828 (estimated)
SponsorIndiana University
Academic / other
Locations5 sites (Birmingham, Alabama and 4 other locations)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT05124808 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women aged 18-45 with a singleton gestation and diagnosed with gestational diabetes while being overweight or obese.

Probably not a fit

Patients with significant fetal anomalies or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized clinical trial involves 828 overweight and obese pregnant women diagnosed with gestational diabetes. The study aims to compare the effects of intensive glycemic targets against standard glycemic targets on perinatal outcomes. Participants will be monitored throughout their pregnancy to assess the impact of these glycemic control strategies on complications associated with gestational diabetes. The trial is conducted across four medical centers in the U.S. with high obesity rates, ensuring a diverse participant pool.

Why it matters

Potential benefit: If successful, this study could lead to improved pregnancy outcomes for overweight and obese women with gestational diabetes.

How similar studies have gone: Previous studies have shown promising results with intensive glycemic control in similar populations, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women between the ages of 18-45
* Singleton gestation
* Gestational age between 12 0/7-32 6/7 weeks' gestation with gestational diabetes diagnosed during this time frame using either a 50g 1-hr GCT ≥200 mg/dL or two or more abnormal values on a 100g OGTT using the Carpenter-Coustan Criteria
* Overweight or obese BMI at the first prenatal visit (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans)

Exclusion Criteria:

* Inability or unwillingness to provide informed consent
* Inability to communicate with members of the study team, despite the presence of an interpreter
* Planned delivery at a non-study affiliated hospital
* Known renal disease with a baseline creatinine \>1.5 mg/dL
* Significant fetal anomalies diagnosed prior to study enrollment (these will include anomalies such as gastroschisis, spina bifida, complex congenital heart disease, or serious karyotypic anomalies that may lead to early delivery or increased risk of neonatal death)
* Oral or IV/IM steroid use within 7 days of study enrollment

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • Indiana University
    Indianapolis, Indiana, United States
    Recruiting
  • University of Oklahoma
    Norman, Oklahoma, United States
    Recruiting
  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Women and Infants Hospital of Rhode Island
    Providence, Rhode Island, United States
    Recruiting

Study contacts

  • Principal investigator: Christina Scifres, MD — Indiana University
  • Study coordinator: Rasika Sadolikar, MBBS, MPH
  • Email: rsadolik@iu.edu
  • Phone: (317)278-8040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.